ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0065

Expression and Co-Localization of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues Precedes the Development of Cardiac Fibrosis in Collagen-Induced Arthritis

Wenxian Zhou1, Hannah Johnson2, Michael Duryee2, Ali Namvaran3, Julian Garcia2, Carlos Hunter2, Tate Johnson2, Daniel Anderson4, Kishore Bidasee2, Geoffrey Thiele2 and Ted Mikuls2, 1University of Nebraska Medical Center, Bellevue, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, 40587964, Durham, NC

Meeting: ACR Convergence 2025

Keywords: Animal Model, autoantigens, Collagen-Induced Arthritis, Heart disease, Mouse Models, RA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0049–0066) Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with rheumatoid arthritis (RA) experience increased morbidity and mortality due to heart failure with preserved ejection fraction (HFpEF), a condition characterized by diastolic dysfunction largely driven by cardiac fibrosis. However, the underlying mechanisms of HFpEF in RA remain poorly understood. Recent studies from our group have identified the synergistic role of post-translational modifications (PTMs)—specifically citrulline (CIT) and malondialdehyde-acetaldehyde (MAA)—in promoting local inflammation and fibrosis in the joints and lungs of RA patients. Furthermore, these PTMs are increasingly expressed and co-localized in heart tissues of mice with early collagen-induced arthritis (CIA), indicating their potential role in promoting cardiac fibrosis and dysfunction. Therefore, the purpose of this study was to evaluate the temporal relationship between the cardiac expression of these PTMs and cardiac fibrosis in CIA mice.

Methods: Arthritis prone male DBA/1J mice were subjected to CIA (n=8) by standard protocols with saline injections used as control (n=6). Three mice per group were sacrificed at 5 weeks (early CIA) with the remainder sacrificed at 10 weeks (chronic CIA). Prior to being euthanized at 10 weeks, transthoracic echocardiography was performed to assess diastolic function (early to late transmitral diastolic flow [E:A] and myocardial relaxation [E’:A’] velocity ratios) and systolic function (left ventricular ejection fraction %). Additionally, bovine serum albumin coupled to fluorescein isothiocyanate (BSA-FITC) was injected into the left ventricle immediately before sacrifice to visualize microvascular leakage. Hearts were resected and myocardial tissues were paraffin-embedded, sectioned, and stained with trichrome to quantify collagen deposition. Statistical comparisons of functional and morphologic features in CIA vs. control mice were performed using Student’s t-test.

Results: Though CIT and MAA expression were increased and co-localized in heart tissues from mice with early CIA, (Zhou et al. ACR Convergence 2024, Abst 0032), there were no differences in myocardial collagen deposition in early CIA vs. control mice (Fig. 1A). In contrast, we observed significantly increased perivascular and interstitial collagen deposition in chronic CIA vs. control mice (Fig. 1B). Mice with chronic CIA also had increased microvascular leakage (Fig. 2), impaired diastolic function (Fig. 3), and diminished systolic function (Fig. 3) vs. controls.

Conclusion: This study is the first to demonstrate that an increase in CIT and MAA deposition in heart tissues precedes the onset of cardiac fibrosis, microvascular leakage and myocardial dysfunction in mice with CIA. Coupled with our recent studies revealing that CIT and MAA synergistically promote the activation of fibroblasts and endothelial cells in vitro, our findings suggest that CIT and MAA together may be significant drivers of cardiac dysfunction in RA. Further research will explore whether inhibitors of CIT, MAA, or their downstream signaling pathways can attenuate cardiac dysfunction in RA.

Supporting image 1Figure 1. Trichrome Stain Demonstrated Increased Cardiac Fibrosis in CIA Mice at Week 10. Representative image of 20X frame at left ventricle was shown. White scale bar at the bottom indicates 200 μm. Tissue fibrosis (blue) was quantified for control and CIA mice A) 5 weeks and B) 10 weeks post injection. Data shown on graphs are mean ± standard deviation.

Supporting image 2Figure 2. BSA-FITC Revealed Increased Microvascular Leakage in CIA Mice at Week 10. n=1 per group. Representative image of 20X frame at left ventricle was shown. Red arrow points to the sites of micro-vessels with FITC leakage. White scale bar at the bottom indicates 200 μm.

Supporting image 3Figure 3. Echocardiography of Collagen Induced Arthritis (CIA) and Control Mice at Week 10. Echocardiography was performed on CIA (n=2) and saline-injected Control Mice (n=2) 10 weeks after the first injection. Raw Echocardiographic data was obtained using Pulse-wave, tissue Doppler, and M-mode, and representative images were shown for: A) Control mice; B) CIA mice. These images were used to measure C) E:A ratio, D) E’:A’ ratio, and E) Ejection fraction, respectively. Low E:A ratio and E’:A’ ratio (normal range 1.52 ± 0.40) indicates diastolic dysfunction, and low ejection fraction (normal range 71 ± 11) indicates systolic dysfunction. Data shown on graphs are mean ± standard deviation.


Disclosures: W. Zhou: None; H. Johnson: None; M. Duryee: None; A. Namvaran: None; J. Garcia: None; C. Hunter: None; T. Johnson: None; D. Anderson: None; K. Bidasee: None; G. Thiele: None; T. Mikuls: Amgen, 2, 5, Merck/MSD, 1, Olatech Therapeutics, 1, UCB, 1.

To cite this abstract in AMA style:

Zhou W, Johnson H, Duryee M, Namvaran A, Garcia J, Hunter C, Johnson T, Anderson D, Bidasee K, Thiele G, Mikuls T. Expression and Co-Localization of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues Precedes the Development of Cardiac Fibrosis in Collagen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/expression-and-co-localization-of-malondialdehyde-acetaldehyde-and-citrullinated-proteins-in-myocardial-tissues-precedes-the-development-of-cardiac-fibrosis-in-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-and-co-localization-of-malondialdehyde-acetaldehyde-and-citrullinated-proteins-in-myocardial-tissues-precedes-the-development-of-cardiac-fibrosis-in-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology